Reumatoloxía

2020

1. A Comparative Study of Doppler Ultrasound against Temporal Artery Biopsy in the Diagnosis of Giant Cell Arteritis

   Reumatologia Clinica, Vol. 16, Núm. 5P1, pp. 313-318

2. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

   Scientific Reports, Vol. 10, Núm. 1

3. A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis

   Scientific Reports, Vol. 10, Núm. 1

4. Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients

   Rheumatology (Oxford, England), Vol. 59, Núm. 12, pp. 3906-3916

5. All-trans retinoic acid inhibits migration and invasiveness of rheumatoid fibroblast-like synoviocytes

   Journal of Pharmacology and Experimental Therapeutics, Vol. 372, Núm. 2, pp. 185-192

6. Amentadione from the Alga Cystoseira usneoides as a Novel Osteoarthritis Protective Agent in an Ex Vivo Co-Culture OA Model

   Marine drugs, Vol. 18, Núm. 12

7. Analyses of the Genetic Polymorphisms rs3740199 and rs1871054 of the ADAM12 Gene and the Alleles at the rs2073508 Loci of the TGFB1 Gene and Their Contribution to Susceptibility to Primary Knee Osteoarthritis

   Genetic Testing and Molecular Biomarkers, Vol. 24, Núm. 6, pp. 375-380

8. Angiopoietin-2 promotes inflammatory activation in monocytes of systemic sclerosis patients

   International Journal of Molecular Sciences, Vol. 21, Núm. 24, pp. 1-10

9. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality

   Lupus, Vol. 29, Núm. 12, pp. 1556-1565

10. Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. A national multicentre study of 51 cases in clinical practice

    Clinical and experimental rheumatology, Vol. 38, Núm. 5, pp. 69-75

11. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662

12. Association between non-adherence behaviors, patients’ experience with healthcare and beliefs in medications: a survey of patients with different chronic conditions

    Current Medical Research and Opinion, Vol. 36, Núm. 2, pp. 293-300

13. Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective study

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 5, pp. 1101-1108

14. Bacteremia in systemic lupus erythematosus in patients from a Spanish registry: Risk factors, clinical and microbiological characteristics, and outcomes

    Journal of Rheumatology, Vol. 47, Núm. 2, pp. 234-240

15. Biologic therapy in refractory non-multiple sclerosis optic neuritis isolated or associated to immune-mediated inflammatory diseases. A multicenter study

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-13

16. Blocking il-17: A promising strategy in the treatment of systemic rheumatic diseases

    International Journal of Molecular Sciences, Vol. 21, Núm. 19, pp. 1-14

17. Caffeine, a risk factor for osteoarthritis and longitudinal bone growth inhibition

    Journal of Clinical Medicine, Vol. 9, Núm. 4

18. Cartilage Metabolism, Mitochondria, and Osteoarthritis

    Journal of the American Academy of Orthopaedic Surgeons, Vol. 28, Núm. 6, pp. E242-E244

19. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance physician-reported registry

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 7, pp. 859-866

20. Chemical exposure-induced systemic fibrosing disorders: Novel insights into systemic sclerosis etiology and pathogenesis

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 6, pp. 1226-1237